{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:04:36Z","timestamp":1786982676064,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s13555-022-00872-1","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T23:30:47Z","timestamp":1672443047000},"page":"581-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-6856","authenticated-orcid":false,"given":"Amit","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley B.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rudnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Jedrzejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pansar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,31]]},"reference":[{"key":"872_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/CCID.S111019","volume":"10","author":"M Napolitano","year":"2017","unstructured":"Napolitano M, Megna M, Timoshchuk EA, et\u00a0al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017;10:105\u201315.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"872_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/1744666X.2016.1221762","volume":"12","author":"CC Zouboulis","year":"2016","unstructured":"Zouboulis CC. Adalimumab for the treatment of hidradenitis suppurativa\/acne inversa. Expert Rev Clin Immunol. 2016;12:1015\u201326.","journal-title":"Expert Rev Clin Immunol"},{"key":"872_CR3","unstructured":"Ballard K, Shuman VL. Hidradenitis suppurativa. In: StatPearls. Treasure Island (FL): StatPearls Publishing 2022."},{"key":"872_CR4","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.jaci.2020.12.651","volume":"147","author":"K Navrazhina","year":"2021","unstructured":"Navrazhina K, Frew JW, Gilleaudeau P, Sullivan-Whalen M, Garcet S, Krueger JG. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. J Allergy Clin Immunol. 2021;147:2213\u201324.","journal-title":"J Allergy Clin Immunol"},{"key":"872_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","volume":"153","author":"A Garg","year":"2017","unstructured":"Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153:760\u20134.","journal-title":"JAMA Dermatol"},{"key":"872_CR6","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/bjd.19435","volume":"183","author":"JR Ingram","year":"2020","unstructured":"Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020;183:990\u20138.","journal-title":"Br J Dermatol"},{"key":"872_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/postgradmedj-2013-131994","volume":"90","author":"DN Dufour","year":"2014","unstructured":"Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014;90:216\u201321.","journal-title":"Postgrad Med J"},{"key":"872_CR8","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/jdv.18163","volume":"36","author":"JR Ingram","year":"2022","unstructured":"Ingram JR, Bettoli V, Espy JI, et\u00a0al. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US. J Eur Acad Dermatol Venereol. 2022;36:1597\u2013605.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"872_CR9","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/ijerph18136709","volume":"18","author":"T Montero-Vilchez","year":"2021","unstructured":"Montero-Vilchez T, Diaz-Calvillo P, Rodriguez-Pozo JA, et\u00a0al. The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18:6709.","journal-title":"Int J Environ Res Public Health"},{"key":"872_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","volume":"27","author":"AJ Onderdijk","year":"2013","unstructured":"Onderdijk AJ, van der Zee HH, Esmann S, et\u00a0al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2013;27:473\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"872_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bpobgyn.2014.07.012","volume":"28","author":"LJ Margesson","year":"2014","unstructured":"Margesson LJ, Danby FW. Hidradenitis suppurativa. Best Pract Res Clin Obstet Gynaecol. 2014;28:1013\u201327.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"872_CR12","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.12968\/bjon.2022.31.4.S34","volume":"31","author":"S Moloney","year":"2022","unstructured":"Moloney S. The challenges of wound management for hidradenitis suppurativa. Br J Nurs. 2022;31:S34-s41.","journal-title":"Br J Nurs"},{"key":"872_CR13","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1111\/bjd.16603","volume":"183","author":"\u0141 Matusiak","year":"2020","unstructured":"Matusiak \u0141. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol. 2020;183:e171\u20137.","journal-title":"Br J Dermatol"},{"key":"872_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/AJP.0b013e3181ceb80c","volume":"26","author":"HS Smith","year":"2010","unstructured":"Smith HS, Chao JD, Teitelbaum J. Painful hidradenitis suppurativa. Clin J Pain. 2010;26:435\u201344.","journal-title":"Clin J Pain"},{"key":"872_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","volume":"6","author":"R Sabat","year":"2020","unstructured":"Sabat R, Jemec GBE, Matusiak \u0141, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6:18.","journal-title":"Nat Rev Dis Primers"},{"key":"872_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","volume":"156","author":"S Reddy","year":"2020","unstructured":"Reddy S, Strunk A, Jemec GBE, Garg A. Incidence of myocardial infarction and cerebrovascular accident in patients with hidradenitis suppurativa. JAMA Dermatol. 2020;156:65\u201371.","journal-title":"JAMA Dermatol"},{"key":"872_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","volume":"86","author":"A Garg","year":"2022","unstructured":"Garg A, Malviya N, Strunk A, et\u00a0al. Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2022;86:1092\u2013101.","journal-title":"J Am Acad Dermatol"},{"key":"872_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jamadermatol.2019.0164","volume":"155","author":"S Reddy","year":"2019","unstructured":"Reddy S, Strunk A, Garg A. Comparative overall comorbidity burden among patients with hidradenitis suppurativa. JAMA Dermatol. 2019;155:797\u2013802.","journal-title":"JAMA Dermatol"},{"key":"872_CR19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2019.06.016","volume":"81","author":"S Reddy","year":"2019","unstructured":"Reddy S, Strunk A, Garg A. All-cause mortality among patients with hidradenitis suppurativa: a population-based cohort study in the United States. J Am Acad Dermatol. 2019;81:937\u201342.","journal-title":"J Am Acad Dermatol"},{"key":"872_CR20","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2019.08.089","volume":"82","author":"SR Goldburg","year":"2020","unstructured":"Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: current and emerging treatments. J Am Acad Dermatol. 2020;82:1061\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"872_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40265-015-0516-5","volume":"76","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Prens EP. An update on medical treatment options for hidradenitis suppurativa. Drugs. 2016;76:215\u201329.","journal-title":"Drugs"},{"key":"872_CR22","unstructured":"U.S. FDA, Orphan Drug Designations and Approvals. https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=446414. Accessed 15 July 2022."},{"key":"872_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4103\/idoj.IDOJ_407_18","volume":"11","author":"D Mitra","year":"2020","unstructured":"Mitra D, Chopra A, Saraswat N, Mitra B, Talukdar K, Agarwal R. Biologics in dermatology: off-label indications. Indian Dermatol Online J. 2020;11:319\u201327.","journal-title":"Indian Dermatol Online J"},{"key":"872_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","volume":"82","author":"A Garg","year":"2020","unstructured":"Garg A, Neuren E, Cha D, et\u00a0al. Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020;82:366\u201376.","journal-title":"J Am Acad Dermatol"},{"key":"872_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000468148","volume":"233","author":"A Strunk","year":"2017","unstructured":"Strunk A, Midura M, Papagermanos V, Alloo A, Garg A. Validation of a case-finding algorithm for hidradenitis suppurativa using administrative coding from a clinical database. Dermatology. 2017;233:53\u20137.","journal-title":"Dermatology"},{"key":"872_CR26","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.12688\/f1000research.26083.1","volume":"9","author":"S Narla","year":"2020","unstructured":"Narla S, Lyons AB, Hamzavi IH. The most recent advances in understanding and managing hidradenitis suppurativa. F1000Res. 2020;9:1049.","journal-title":"F1000Res"},{"key":"872_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030579","volume":"9","author":"J Marvel","year":"2019","unstructured":"Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019;9: e030579.","journal-title":"BMJ Open"},{"key":"872_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamadermatol.2015.4593","volume":"152","author":"A Garg","year":"2016","unstructured":"Garg A, Besen J, Legler A, Lam CS. Factors associated with point-of-care treatment decisions for hidradenitis suppurativa. JAMA Dermatol. 2016;152:553\u20137.","journal-title":"JAMA Dermatol"},{"key":"872_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000480379","volume":"233","author":"A Garg","year":"2017","unstructured":"Garg A, Lavian J, Strunk A. Low utilization of the dermatology ambulatory encounter among patients with hidradenitis suppurativa: a population-based retrospective cohort analysis in the USA. Dermatology. 2017;233:396\u20138.","journal-title":"Dermatology"},{"key":"872_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/10826084.2018.1517175","volume":"54","author":"LE Dayer","year":"2019","unstructured":"Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: three decades of change. Subst Use Misuse. 2019;54:331\u20139.","journal-title":"Subst Use Misuse"},{"key":"872_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.36687","volume":"4","author":"B Lee","year":"2021","unstructured":"Lee B, Zhao W, Yang KC, Ahn YY, Perry BL. Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007\u20132018. JAMA Netw Open. 2021;4: e2036687.","journal-title":"JAMA Netw Open"},{"key":"872_CR32","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamadermatol.2019.2610","volume":"155","author":"S Reddy","year":"2019","unstructured":"Reddy S, Orenstein LAV, Strunk A, Garg A. Incidence of long-term opioid use among opioid-naive patients with hidradenitis suppurativa in the United States. JAMA Dermatol. 2019;155:1284\u201390.","journal-title":"JAMA Dermatol"},{"key":"872_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","volume":"79","author":"A Garg","year":"2018","unstructured":"Garg A, Papagermanos V, Midura M, Strunk A, Merson J. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States. J Am Acad Dermatol. 2018;79:495-500.e1.","journal-title":"J Am Acad Dermatol"},{"key":"872_CR34","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jaad.2020.07.108","volume":"84","author":"LAV Orenstein","year":"2021","unstructured":"Orenstein LAV, Wright S, Strunk A, Garg A. Low prescription of tumor necrosis alpha inhibitors in hidradenitis suppurativa: a cross-sectional analysis. J Am Acad Dermatol. 2021;84:1399\u2013401.","journal-title":"J Am Acad Dermatol"},{"key":"872_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/bjd.17101","volume":"181","author":"T Tzellos","year":"2019","unstructured":"Tzellos T, Yang H, Mu F, Calimlim B, Signorovitch J. Impact of hidradenitis suppurativa on work loss, indirect costs and income. Br J Dermatol. 2019;181:147\u201354.","journal-title":"Br J Dermatol"},{"key":"872_CR36","doi-asserted-by":"crossref","unstructured":"De DR, Shih T, Fixsen D, Brooks B, Hsiao JL, Shi VY. Biologic use in hidradenitis suppurativa: patient perspectives and barriers. J Dermatol Treat. 2022;1\u20133.","DOI":"10.1111\/ijd.16371"},{"key":"872_CR37","unstructured":"Quick Facts, U.S. Census Bureau. https:\/\/www.census.gov\/quickfacts\/fact\/table\/US#. Accessed 15 July 2022."},{"key":"872_CR38","unstructured":"Keisler-Starkey K, Bunch LN. Health insurance coverage in the United States: 2020. U.S. Census Bureau. 2021"},{"key":"872_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","volume":"77","author":"A Garg","year":"2017","unstructured":"Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017;77:118\u201322.","journal-title":"J Am Acad Dermatol"},{"key":"872_CR40","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/jamadermatol.2018.2117","volume":"154","author":"S Wertenteil","year":"2018","unstructured":"Wertenteil S, Strunk A, Garg A. Association of low socioeconomic status with hidradenitis suppurativa in the United States. JAMA Dermatol. 2018;154:1086\u20138.","journal-title":"JAMA Dermatol"},{"key":"872_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2105\/AJPH.93.5.742","volume":"93","author":"G Becker","year":"2003","unstructured":"Becker G, Newsom E. Socioeconomic status and dissatisfaction with health care among chronically ill African Americans. Am J Public Health. 2003;93:742\u20138.","journal-title":"Am J Public Health"},{"key":"872_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/bjd.13041","volume":"171","author":"GE Kim","year":"2014","unstructured":"Kim GE, Shlyankevich J, Kimball AB. The validity of the diagnostic code for hidradenitis suppurativa in an electronic database. Br J Dermatol. 2014;171:338\u201342.","journal-title":"Br J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00872-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T22:21:16Z","timestamp":1675030876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00872-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["872"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00872-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,31]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}